Spots Global Cancer Trial Database for mobilization
Every month we try and update this database with for mobilization cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy | NCT02139280 | Hematologic Mal... | Cyclophosphamid... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children | NCT00695370 | Solid Malignanc... | Pegfilgrastim (... | - 18 Years | University Hospital, Clermont-Ferrand | |
| Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma | NCT00006184 | Multiple Myelom... | Myeloma Immunog... Bortezomib Cyclophosphamid... Cyclosporine Doxorubicin hyd... Etoposide Fludarabine pho... Prednisone Vincristine Sul... Methotrexate GMCSF (granuloc... GCSF (granulocy... | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy | NCT02139280 | Hematologic Mal... | Cyclophosphamid... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients | NCT01010880 | Multiple Myelom... | BKT140 | 16 Years - 65 Years | Biokine Therapeutics Ltd | |
| Collection of Transplant Stem Cells for Plasma Cell Myeloma | NCT01547806 | Plasma Cell Mye... Multiple Myelom... | Filgrastim Plerixafor Apheresis | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children | NCT00695370 | Solid Malignanc... | Pegfilgrastim (... | - 18 Years | University Hospital, Clermont-Ferrand | |
| Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients | NCT01010880 | Multiple Myelom... | BKT140 | 16 Years - 65 Years | Biokine Therapeutics Ltd | |
| Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma | NCT00006184 | Multiple Myelom... | Myeloma Immunog... Bortezomib Cyclophosphamid... Cyclosporine Doxorubicin hyd... Etoposide Fludarabine pho... Prednisone Vincristine Sul... Methotrexate GMCSF (granuloc... GCSF (granulocy... | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Using Pedometers for the Assessment and Enhancement of Mobility in Gynaecological and Oncological Patients Following Surgery. | NCT04711421 | Surgery Mobilization Gynecologic Can... | 4 VIVOFIT- | 18 Years - 99 Years | Tel-Aviv Sourasky Medical Center | |
| Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma Subjects | NCT01091831 | Multiple Myelom... | Cyclophosphamid... Lenalidomide Dexamethasone Melphalan | 18 Years - 65 Years | Fondazione EMN Italy Onlus | |
| Pegfilgrastim PBPC Mobilization Study | NCT00066092 | Lymphoma Hodgkin's Lymph... Non-Hodgkin's L... Hematology Oncology | pegfilgrastim 1... filgrastim pegfilgrastim 6... | 18 Years - | Amgen | |
| Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization. | NCT00299780 | Lymphoma Multiple Myelom... Acute Myelogeno... | Stem cell mobil... | 18 Years - 75 Years | Massachusetts General Hospital | |
| Survey Of Mobilisation and Breathing Exercises After Thoracic and Abdominal Surgery | NCT04729634 | Abdominal Cance... Heart Diseases | Mobilization | - | Göteborg University | |
| Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer | NCT00001507 | Breast Neoplasm Neoplasm Metast... | Monoclonal Anti... Monoclonal Anti... Monoclonal Anti... Baxter Isolex 3... Ceprate SC | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Procedural Pain in Palliative Care: Prevalence, Intensity and Treatment | NCT02437929 | Breakthrough Pa... Pain Due to Cer... Pain Cancer Terminal Diseas... | Mobilization Positioning Personal Hygien... Bladder cathete... Wound care Subcutaneous dr... | 18 Years - | Antea Foundation | |
| Procedural Pain in Palliative Care: Prevalence, Intensity and Treatment | NCT02437929 | Breakthrough Pa... Pain Due to Cer... Pain Cancer Terminal Diseas... | Mobilization Positioning Personal Hygien... Bladder cathete... Wound care Subcutaneous dr... | 18 Years - | Antea Foundation | |
| Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy | NCT02139280 | Hematologic Mal... | Cyclophosphamid... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells | NCT00400556 | Multiple Myelom... Cutaneous Lymph... | ATRA plus G-CSF... | 18 Years - 70 Years | Peter MacCallum Cancer Centre, Australia | |
| Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma | NCT02722733 | Hodgkin's Lymph... Non-Hodgkin's L... | G-CSF (filgrast... Cytosine arabin... | 18 Years - 65 Years | Maria Sklodowska-Curie National Research Institute of Oncology | |
| Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma | NCT02722733 | Hodgkin's Lymph... Non-Hodgkin's L... | G-CSF (filgrast... Cytosine arabin... | 18 Years - 65 Years | Maria Sklodowska-Curie National Research Institute of Oncology | |
| Survey Of Mobilisation and Breathing Exercises After Thoracic and Abdominal Surgery | NCT04729634 | Abdominal Cance... Heart Diseases | Mobilization | - | Göteborg University | |
| Procedural Pain in Palliative Care: Prevalence, Intensity and Treatment | NCT02437929 | Breakthrough Pa... Pain Due to Cer... Pain Cancer Terminal Diseas... | Mobilization Positioning Personal Hygien... Bladder cathete... Wound care Subcutaneous dr... | 18 Years - | Antea Foundation | |
| Patient Activation Through Counseling, Exercise and Mobilization | NCT03411200 | Pancreas Cancer Biliary Tract C... Non Small Cell ... Advanced Cancer | Multimodal and ... | 65 Years - | Herlev and Gentofte Hospital | |
| Pegfilgrastim PBPC Mobilization Study | NCT00066092 | Lymphoma Hodgkin's Lymph... Non-Hodgkin's L... Hematology Oncology | pegfilgrastim 1... filgrastim pegfilgrastim 6... | 18 Years - | Amgen | |
| Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients | NCT00551928 | Multiple Myelom... Newly Diagnosed... | Melphalan Lenalidomide Prednisone Melphalan | 18 Years - 65 Years | Fondazione EMN Italy Onlus | |
| Collection of Transplant Stem Cells for Plasma Cell Myeloma | NCT01547806 | Plasma Cell Mye... Multiple Myelom... | Filgrastim Plerixafor Apheresis | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Multiple Myeloma Patients. | NCT01908621 | Multiple Myelom... | G-CSF (filgrast... Cytosine arabin... | 18 Years - 65 Years | Maria Sklodowska-Curie National Research Institute of Oncology | |
| Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients | NCT00551928 | Multiple Myelom... Newly Diagnosed... | Melphalan Lenalidomide Prednisone Melphalan | 18 Years - 65 Years | Fondazione EMN Italy Onlus |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
